Notice Number: NOT-DA-19-071
Key Dates
Release Date: August 28, 2019
PAR-19-345
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of this notice is to inform potential applicants of correction to the AIDS application receipt date for PAR-19-345 " NIDA Program Project Grant Applications (P01 Clinical Trial Optional)". A due date for AIDS applications for January 2020 Council has been added; this new AIDS date is September 30, 2019. The remaining due dates are unchanged. The due dates for May 2020 council remain September 25, 2019 (non-AIDS applications) and January 7, 2020, (AIDS applications).
The FOA has been modified as follows:
Part 1. Overview Information
Key Dates
Currently Reads:
AIDS Application Due Date(s)
The first AIDS application due date for this FOA is January 7, 2020
Modified to Read:
AIDS Application Due Date(s)
The first AIDS application due date for this FOA is September 30, 2019. Following this date, standard dates apply.
** Please note, this receipt date (September 30, 2019) for AIDS applications will go to January 2020 Council and beyond that standard dates apply.**
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Kevin Walton, Ph.D.
Division of Therapeutics and Medical Consequences
National Institute on Drug Abuse(NIDA)
Telephone: 301-827-5980
Email: waltonkm@nida.nih.gov
Meyer D. Glantz, Ph.D.
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: mglantz@nida.nih.gov
Jonathan D. Pollock, Ph.D.
Division of Neuroscience and Behavior
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1316
Email: npilotte@mail.nih.gov
Steven Grant, Ph.D.
Division of Neuroscience and Behavior
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-4877
Email: sgrant@nida.nih.gov
and Human Services (HHS)
